Fundraising Fox
InspireMD
NASDAQ: NSPRMiami, US · Delaware corporation · 1 known investors
Find your way into InspireMD
Sign up to see every warm intro you have to InspireMD
- Paths you didn't know you had: your email and LinkedIn already hold routes to the InspireMD team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
InspireMD develops and commercializes medical devices for vascular intervention, including carotid stent systems and embolic protection systems sold through direct sales in the United States and via distributors in international markets.
Founders & leadership
ML
Mike LawlessChief Financial Officer
SG
Shane GleasonChief Commercial Officer & General ManagerShane Gleason held leadership roles in clinical and commercial operations at medical device companies including TriVascular, Cordis, Abbott, and Nuvaira, where he oversaw sales team management, regulatory strategy, and product launches in vascular intervention and cardiac therapies.
MS
Marvin SlosmanChief Executive OfficerMarvin Slosman is Chief Executive Officer of InspireMD, a medical device company commercializing vascular intervention products including carotid stent systems. He brings over 35 years of experience in medical device development, clinical and regulatory strategy, commercial launch, and capital raising across private and public companies.
AT
Andrea TommasoliChief Operating Officer
AM
Alan MilinazzoExecutive
CS
JB
James BarryExecutive
Board
Investors · 1
OrbiMedlisted by OrbiMedNew York · $1M – $75M
How we know: OrbiMed's portfolio page · funding news · stocktitan.net · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$83.8M disclosed across 5 of 6 rounds · 2016–2025
▶$40.1MraisedAug 2025 · 18 investors · Other Health CareRule 506(b)
▶$40.1MraisedAug 2025 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Raymond CohenDirector
- Thomas J. KesterDirector
- Scott R. WardDirector
- Patrick VertaExecutive Officer
- Kathryn ArnoldDirector
- Pete LigottiExecutive Officer
- Mike LawlessExecutive Officer
- Shane GleasonExecutive Officer
- Marvin SlosmanExecutive Officer, Director
- Michael BermanDirector
- Gary Roubin, M.D.Director
- Andrea TommasoliExecutive Officer
- Paul StukaDirector
- Offering amount
- $40.1M
- Amount sold
- $40.1M
- Sales commissions
- $2.4M
- Placement agents
- BofA Securities, Inc.
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$42.2MraisedMay 2023 · 18 investors · Other Health CareRule 506(b)
▶$42.2MraisedMay 2023 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Shane GleasonExecutive Officer
- Thomas J. KesterDirector
- Paul StukaDirector
- Michael BermanDirector
- Marvin SlosmanExecutive Officer, Director
- Gary Roubin, M.D.Director
- Craig ShoreExecutive Officer
- Andrea TommasoliExecutive Officer
- Kathryn ArnoldDirector
- Offering amount
- $42.2M
- Amount sold
- $42.2M
- Sales commissions
- $4.2M
- Placement agents
- Piper Sandler & Co., A.G.P./Alliance Global Partners, LifeSci Capital LLC
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KraisedDec 2017 · 1 investors · BiotechnologyRule 506(b)
▶$750KraisedDec 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Campbell RogersDirector
- Paul StukaDirector
- Thomas KesterDirector
- James BarryExecutive Officer, Director
- Michael BermanDirector
- Craig ShoreExecutive Officer
- Offering amount
- $750K
- Amount sold
- $750K
- Minimum investment
- $750K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$182.4KraisedJun 2016 · 1 investors · BiotechnologyRule 506(b)
▶$182.4KraisedJun 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sol BarerDirector
- Campbell RogersDirector
- Isaac BlechDirector
- James BarryExecutive Officer, Director
- Craig ShoreExecutive Officer
- Paul StukeDirector
- Michael BermanDirector
- Offering amount
- $182.4K
- Amount sold
- $182.4K
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$609.5KraisedMar 2016 · 4 investors · BiotechnologyRule 506(b)
▶$609.5KraisedMar 2016 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alan MilinazzoExecutive Officer, Director
- Michael BermanDirector
- Sol BarerDirector
- Campbell RogersDirector
- Isaac BlechDirector
- James LoughlinDirector
- Craig ShoreExecutive Officer
- Paul StukeDirector
- James BarryExecutive Officer, Director
- Offering amount
- $609.5K
- Amount sold
- $609.5K
- Sales commissions
- $48.8K
- Placement agents
- Dawson James Securities, Inc.
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$44.5Mvaluation at IPOFeb 2021 · $0.62/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 3
Inspire MedicalInspire Medical Systems develops an FDA-approved implantable device that treats obstructive sleep apnea (OSA) by working with the patient's natural breathing, controlled via a small remote and intended for patients for whom CPAP is not effective. The device is surgically placed by an ENT and configured by a sleep medicine professional.
Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
QuiverquantQuiver Quantitative scrapes and aggregates alternative stock market data from across the internet into a free web dashboard. It targets retail investors, giving non-professional traders access to alternative data typically reserved for institutional money managers.
Companies working in the same space as InspireMD.
In the news
Frequently asked questions
- What does InspireMD do?
- InspireMD develops and commercializes medical devices for vascular intervention, including carotid stent systems and embolic protection systems sold through direct sales in the United States and via distributors in international markets.
- Who are InspireMD's investors?
- InspireMD's investors include OrbiMed.
- How much funding has InspireMD raised?
- InspireMD has disclosed $83.8M raised across 5 of its 6 known rounds.
- Where is InspireMD headquartered?
- InspireMD is headquartered in Miami, US.